Verona Pharma PLC (VRNA)
38.81
+0.95
(+2.51%)
USD |
NASDAQ |
Nov 22, 16:00
38.79
-0.02
(-0.05%)
After-Hours: 20:00
Verona Pharma Cash from Investing (Quarterly): 0.00 for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.00 |
| June 30, 2024 | -0.029M |
| March 31, 2024 | -0.016M |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | -0.029M |
| March 31, 2022 | 0.00 |
| December 31, 2021 | -0.001M |
| September 30, 2021 | -0.011M |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | -0.009M |
| Date | Value |
|---|---|
| September 30, 2020 | -0.068M |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 9.787M |
| December 31, 2019 | -1.703M |
| September 30, 2019 | 22.57M |
| June 30, 2019 | 14.67M |
| March 31, 2019 | 11.78M |
| December 31, 2018 | -4.482M |
| September 30, 2018 | -11.34M |
| June 30, 2018 | 16.29M |
| March 31, 2018 | 6.240M |
| December 31, 2017 | 6.537M |
| September 30, 2017 | -31.64M |
| June 30, 2017 | -41.70M |
| March 31, 2017 | -0.0437M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-1.703M
Minimum
Dec 2019
9.787M
Maximum
Mar 2020
0.3961M
Average
--
Median
Jun 2020
Cash from Investing (Quarterly) Benchmarks
| TC BioPharm (Holdings) PLC | -0.0071M |
| Adaptimmune Therapeutics PLC | -66.02M |
| Biodexa Pharmaceuticals PLC | -- |
| NuCana PLC | -0.0053M |
| Autolus Therapeutics PLC | -9.589M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -62.66M |
| Cash from Financing (Quarterly) | -7.087M |
| Free Cash Flow | -103.81M |
| Free Cash Flow Per Share (Quarterly) | -0.7688 |
| Free Cash Flow to Equity (Quarterly) | -62.98M |
| Free Cash Flow to Firm (Quarterly) | -57.49M |
| Free Cash Flow Yield | -3.31% |